Results 81 to 90 of about 82,702 (262)

Hölder continuity of weak solutions to evolution equations with distributed order fractional time derivative

open access: yesMathematische Annalen
AbstractWe study the regularity of weak solutions to evolution equations with distributed order fractional time derivative. We prove a weak Harnack inequality for nonnegative weak supersolutions and Hölder continuity of weak solutions to this problem.
Adam Kubica   +2 more
openaire   +4 more sources

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

A Hybrid Scheme for the Near Wall Treatment of Building Cube Method

open access: yesJournal of Fluid Science and Technology, 2012
In this paper we explore a new hybrid method for the near wall treatment of viscous computation with block structured Cartesian mesh. Cloud of points are generated to resolve the near wall boundary layer and most of the points are distributed on one ...
Xinrong SU   +2 more
doaj   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

open access: yesMolecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix   +13 more
wiley   +1 more source

An efficient collocation method based on Legendre and Romanovski polynomials for solving Riesz distributed fractional differential equations

open access: yesAlexandria Engineering Journal
In this article, we provide effective numerical solutions with high accuracy and exponential convergence for Riesz distributed fractional differential equations.
Ammar Lachin   +2 more
doaj   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Design of a Fractional Order Frequency PID Controller for an Islanded Microgrid: A Multi-Objective Extremal Optimization Method

open access: yesEnergies, 2017
Fractional order proportional-integral-derivative(FOPID) controllers have attracted increasing attentions recently due to their better control performance than the traditional integer-order proportional-integral-derivative (PID) controllers.
Huan Wang   +5 more
doaj   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy